Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together?

被引:98
作者
Berni, A. [1 ]
Malandrino, D. [2 ]
Parenti, G. [3 ]
Maggi, M. [4 ,5 ]
Poggesi, L. [2 ]
Peri, A. [3 ,4 ]
机构
[1] Careggi Univ Hosp, Internal Med Unit 3, Florence, Italy
[2] Univ Florence, Careggi Univ Hosp, Dept Expt & Clin Med, Florence, Italy
[3] Careggi Univ Hosp, Pituitary Dis & Sodium Alterat Unit, Endocrinol, Florence, Italy
[4] Univ Florence, Careggi Univ Hosp, Dept Expt & Clin Biomed Sci Mario Serio, Endocrinol, I-50139 Florence, Italy
[5] Consorzio INBB, I-00136 Rome, Italy
关键词
Hyponatremia; COVID-19; Interleukin-6 (IL-6); PaO2; FiO(2) ratio; Tocilizumab;
D O I
10.1007/s40618-020-01301-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1137 / 1139
页数:3
相关论文
共 5 条
[1]   Moderate Hyponatremia Is Associated with Increased Risk of Mortality: Evidence from a Meta-Analysis [J].
Corona, Giovanni ;
Giuliani, Corinna ;
Parenti, Gabriele ;
Norello, Dario ;
Verbalis, Joseph G. ;
Forti, Gianni ;
Maggi, Mario ;
Peri, Alessandro .
PLOS ONE, 2013, 8 (12)
[2]   The syndrome of inappropriate antidiuresis (SIAD) [J].
Cuesta, Martin ;
Thompson, C. J. .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 30 (02) :175-187
[3]   SIADH in Systemic JIA Resolving After Treatment With an IL-6 Inhibitor [J].
Hodax, Juanita K. ;
Bialo, Shara R. ;
Yalcindag, Ali .
PEDIATRICS, 2018, 141 (01)
[4]   Tocilizumab treatment in COVID-19: A single center experience [J].
Luo, Pan ;
Liu, Yi ;
Qiu, Lin ;
Liu, Xiulan ;
Liu, Dong ;
Li, Juan .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (07) :814-818
[5]   A Systematic Review of COVID-19 Epidemiology Based on Current Evidence [J].
Park, Minah ;
Cook, Alex R. ;
Lim, Jue Tao ;
Sun, Yinxiaohe ;
Dickens, Borame L. .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)